PPM1M and prostate adenocarcinoma: As shown in Figure 1B, PPM1M was expressed in bladder urothelial carcinoma (BLCA), breast invasive cancer (BRCA), cholangiocarcinoma (CHOL), kidney chromophobe (KICH), kidney renal clear cell cancer (KIRC), kidney renal papillary cell cancer (KIRP), liver hepatocellular cancer (LIHC), lung adenocarcinoma (LUAD), lung squamous cell carcinoma (LUSC), prostate adenocarcinoma (PRAD), thyroid cancer (THCA), and uterine corpus endometrial cancer (UCEC) at higher levels than in paired normal tissues (P < .001).